The Ann Romney Center for Neurologic Diseases is transforming the future of medicine through novel forms of collaboration and patient-centered research. This collaboration—within and outside our walls—is accelerating the search for treatments, prevention, and cures for five of the world’s most complex neurologic diseases.
By bringing together researchers and scientists working across each of the five disease states, the Ann Romney Center for Neurologic Diseases aims to drive new ways of thinking that will create fertile ground for discovering new breakthroughs and imagining new therapies.
Multiple sclerosis is a disease that affects the myelin sheath surrounding nerve fibers in the brain. Our researchers are dedicated to advancing new treatments for the 2.5 million people living with MS.
Alzheimer’s disease damages the nerve cells in the brain that are responsible for cognition. BWH has long been at the forefront of Alzheimer’s research, and is spearheading the first-ever prevention trial in older individuals who may be at risk.
ALS affects the motor neurons in the spinal cord, leading to paralysis of motor functions such as breathing. Cutting-edge research is paving the way for innovative treatments that attack ALS at its molecular core.
Parkinson’s disease involves the degeneration of nerve cells deep in the brain, leading to slowness of movement, tremor, and impairment of cognition. Our work has the potential to lead to new breakthroughs, giving hope to millions of patients and families.
Brain tumors can be one of the most lethal forms of cancer. Our researchers are pursuing new therapies to eliminate tumor cells that are actively resisting the body’s defense mechanisms.
The following is a list of funding resources for fellows, investigators, principal investigators, and staff. These resources are not endorsed by Brigham and Women's Hospital, but are provided as a courtesy and convenience.